Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 199.96%144.96M | ---- | 116.73%48.33M | ---- | 68.00%-288.85M | ---- | -15.10%-902.59M | ---- | -34.52%-784.19M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 28.81%-28.58M | ---- | 5.33%-40.14M | ---- | -200.54%-42.4M | ---- | -585.57%-14.11M | ---- | -120.11%-2.06M |
| Investment loss (gain) | ---- | 127.15%899K | ---- | ---3.31M | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | -14.99%3.12M | ---- | 86.29%3.67M | ---- | -56.02%1.97M | ---- | 426.71%4.48M | ---- | -68.15%850K |
| -Other impairments and provisions | ---- | -14.99%3.12M | ---- | 86.29%3.67M | ---- | -56.02%1.97M | ---- | 426.71%4.48M | ---- | -68.15%850K |
| Revaluation surplus: | ---- | -16.02%-19.63M | ---- | -31.33%-16.92M | ---- | -15,234.52%-12.88M | ---- | ---84K | ---- | ---- |
| -Other fair value changes | ---- | -16.02%-19.63M | ---- | -31.33%-16.92M | ---- | -15,234.52%-12.88M | ---- | ---84K | ---- | ---- |
| Asset sale loss (gain): | ---- | 8,500.00%86K | ---- | -98.41%1K | ---- | 130.58%63K | ---- | ---206K | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 8,500.00%86K | ---- | -98.41%1K | ---- | 130.58%63K | ---- | ---206K | ---- | ---- |
| Depreciation and amortization: | ---- | -22.17%61.98M | ---- | -20.73%79.63M | ---- | 40.64%100.46M | ---- | 55.20%71.43M | ---- | 83.17%46.03M |
| -Amortization of intangible assets | ---- | -4.67%42.22M | ---- | -37.28%44.29M | ---- | 47.46%70.61M | ---- | 41.60%47.89M | ---- | 62.98%33.82M |
| Financial expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 56.85%14.95M |
| Special items | ---- | 84.46%12.74M | ---- | 585.86%6.9M | ---- | -100.61%-1.42M | ---- | 51.53%231.43M | ---- | 1,210.62%152.73M |
| Operating profit before the change of operating capital | ---- | 124.63%175.58M | ---- | 132.16%78.16M | ---- | 60.13%-243.06M | ---- | -6.64%-609.65M | ---- | -6.88%-571.7M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -107.56%-659K | ---- | 176.68%8.72M | ---- | -534.62%-11.37M | ---- | 138.38%2.62M | ---- | ---6.82M |
| Accounts receivable (increase)decrease | ---- | -542.08%-426.48M | ---- | 83.55%-66.42M | ---- | -167.48%-403.68M | ---- | 38.38%-150.92M | ---- | 40.85%-244.9M |
| Accounts payable increase (decrease) | ---- | 132.08%497.04M | ---- | 6.86%214.17M | ---- | -3.53%200.41M | ---- | -19.37%207.76M | ---- | -11.82%257.67M |
| Special items for working capital changes | ---- | 336.78%2.15M | ---- | 54.60%-908K | ---- | ---2M | ---- | ---- | ---- | ---- |
| Cash from business operations | -183.23%-70.88M | 5.95%247.63M | 289.48%85.16M | 150.84%233.72M | 107.97%21.87M | 16.45%-459.7M | 38.86%-274.24M | 2.75%-550.19M | ---448.55M | 13.85%-565.75M |
| Other taxs | 89.20%-508K | 42.95%-5.07M | 32.19%-4.7M | ---8.88M | ---6.94M | ---- | ---- | ---- | ---- | ---685K |
| Interest received - operating | -54.43%8.54M | -29.16%29.36M | -3.41%18.74M | -7.92%41.45M | -15.49%19.4M | 149.29%45.01M | 182.65%22.95M | 506.28%18.06M | --8.12M | 296.54%2.98M |
| Net cash from operations | -163.36%-62.85M | 2.12%271.92M | 188.97%99.19M | 164.21%266.29M | 113.66%34.33M | 22.07%-414.69M | 42.94%-251.29M | 5.56%-532.14M | ---440.43M | 14.10%-563.46M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 79.01%3.68M | --1.07M | 120.11%2.06M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---400M | 200.00%48M |
| Sale of fixed assets | 101.59%633K | 407.55%538K | 492.45%314K | -54.51%106K | -86.45%53K | -82.51%233K | 128.65%391K | 397.01%1.33M | --171K | 1,388.89%268K |
| Purchase of fixed assets | -728.95%-26.25M | -97.36%-15.42M | -55.70%-3.17M | 16.45%-7.81M | 43.52%-2.03M | 45.33%-9.35M | 39.07%-3.6M | -103.20%-17.11M | ---5.91M | -199.72%-8.42M |
| Purchase of intangible assets | 44.13%-14.37M | 47.19%-32.31M | 34.18%-25.71M | 38.34%-61.18M | 28.05%-39.07M | -35.93%-99.21M | -92.79%-54.31M | -8.41%-72.99M | ---28.17M | -1.85%-67.32M |
| Sale of subsidiaries | ---- | ---- | ---- | --55.67M | --55.67M | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | --6.08M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | 82.91%2.59B | 20.23%3.03B | 0.60%1.42B | 26.44%2.52B | 36.25%1.41B | --1.99B | --1.03B | ---- | ---- | ---- |
| Cash on investment | -50.94%-2.72B | -64.25%-3.63B | -28.57%-1.8B | 12.55%-2.21B | 7.42%-1.4B | -665.83%-2.53B | ---1.51B | ---330M | ---- | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3M |
| Net cash from investment operations | 60.04%-164.24M | -318.52%-643.82M | -1,838.38%-411.04M | 145.74%294.63M | 104.42%23.65M | -55.20%-644.19M | -23.72%-535.51M | -1,360.67%-415.08M | ---432.84M | 75.49%-28.42M |
| Net cash before financing | 27.18%-227.08M | -166.30%-371.9M | -637.94%-311.85M | 152.97%560.92M | 107.37%57.97M | -11.79%-1.06B | 9.90%-786.8M | -60.04%-947.21M | ---873.27M | 23.32%-591.87M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -95.10%41.92M | --41.92M | -2.78%854.98M |
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 61.21%-409M | ---409M | -236.84%-1.05B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.76B | ---- | ---- |
| Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 67.71%-5.62M | ---5.62M | -90.24%-17.39M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 70.07%1.83B | --1.83B | 171.36%1.08B |
| Issuance expenses and redemption of securities expenses | ---- | -267.25%-144.25M | ---128.39M | ---39.28M | ---- | ---- | ---- | ---57.65M | ---- | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---52.37M | ---653K | ---- | ---- | 223.08%80M | --80M | 40.51%-65M |
| Net cash from financing operations | 94.48%-7.45M | -32.10%-158.59M | -781.00%-134.91M | -448.22%-120.05M | -52.69%-15.31M | -100.68%-21.9M | -100.65%-10.03M | 310.64%3.22B | --1.53B | -7.01%784.05M |
| Effect of rate | -122.90%-166K | 491.22%579K | 87.82%725K | -125.52%-148K | 20.25%386K | -75.20%580K | --321K | --2.34M | ---- | ---- |
| Net Cash | 47.50%-234.53M | -220.33%-530.49M | -1,147.29%-446.76M | 140.79%440.87M | 105.35%42.66M | -147.56%-1.08B | -221.08%-796.83M | 1,082.43%2.27B | --658.09M | 169.59%192.18M |
| Begining period cash | -27.91%1.37B | 30.23%1.9B | 30.23%1.9B | -42.56%1.46B | -42.56%1.46B | 863.39%2.54B | 863.39%2.54B | 269.59%263.47M | --263.47M | --71.29M |
| Cash at the end | -21.93%1.13B | -27.91%1.37B | -3.22%1.45B | 30.23%1.9B | -13.82%1.5B | -42.56%1.46B | 89.00%1.74B | 863.39%2.54B | --921.55M | 269.59%263.47M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PwC Accounting Firm | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.